Serum sodium predicts mortality in patients listed for liver transplantation
Scott W. Biggins, Harry J. Rodriguez, Peter Bacchetti, Nathan M. Bass, John P. Roberts, Norah A. Terrault – 23 December 2004 – With the implementation of the model for end‐stage liver disease (MELD), refractory ascites, a known predictor of mortality in cirrhosis, was removed as a criterion for liver allocation. Because ascites is associated with low serum sodium, we evaluated serum sodium as an independent predictor of mortality in patients with cirrhosis who were listed for liver transplantation and whether the addition of serum sodium to MELD was superior to MELD alone.